Aristo Bio-Tech And Lifescience Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 26-12-2023
- Paid Up Capital ₹ 6.81 Cr
as on 26-12-2023
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 57.60 Cr
as on 26-12-2023
- Satisfied Charges ₹ 9.61 Cr
as on 26-12-2023
- Revenue -16.86%
(FY 2021)
- Profit 9.59%
(FY 2021)
- Ebitda 9.89%
(FY 2021)
- Net Worth 8.57%
(FY 2021)
- Total Assets -7.33%
(FY 2021)
About Aristo Bio-Tech And Lifescience
The Corporate was formerly known as Aristo Bio-Tech And Lifescience Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 6.81 Cr.
The company currently has active open charges totaling ₹57.60 Cr. The company has closed loans amounting to ₹9.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Aristo Bio-Tech And Lifescience Limited India are Chinmay Chokshi as COMPANY SECRETARY and Ketankumar Joshi as Cfo. Kusum Barhat, Rashmi Otavani, Laxman Rathore, and Three other members serve as directors at the Company.
- CIN/LLPIN
U01100GJ2005PLC127397
- Company No.
152037
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2005
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aristo Bio-Tech And Lifescience Limited offer?
Aristo Bio-Tech And Lifescience Limited offers a wide range of products and services, including Insecticides and Pesticides, Fungicides, Termiticide, Bispyribac Sodium, Ziram, Imidacloprid, Herbicides, Plant Growth Regulators, Chlorpyrifos, Acaricide.
Who are the key members and board of directors at Aristo Bio-Tech And Lifescience?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ketankumar Joshi | CFO | 10-Sep-2018 | Current |
Chinmay Chokshi | Company Secretary | Current | |
Narendra Barhat | Managing Director | 17-Mar-2005 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rashmi Otavani | Director | 20-Mar-2022 | Current |
Kusum Barhat | Director | 17-Mar-2005 | Current |
Laxman Rathore | Director | 10-Sep-2018 | Current |
Raghavender Mateti | Director | 10-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Aristo Bio-Tech And Lifescience.
Aristo Bio-Tech And Lifescience Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 16.86% decrease. The company also saw a slight improvement in profitability, with a 9.59% increase in profit. The company's net worth moved up by a moderate rise of 8.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Aristo Bio-Tech And Lifescience?
In 2021, Aristo Bio-Tech And Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Barhatji Mewar (Paaner) FoundationActive 1 month 9 days
Kusum Barhat and Narendra Barhat are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 20 Sep 2022 | ₹1.36 Cr | Open |
Others Creation Date: 24 Nov 2021 | ₹3.18 Cr | Open |
Others Creation Date: 02 Dec 2020 | ₹1.73 Cr | Open |
How Many Employees Work at Aristo Bio-Tech And Lifescience?
Aristo Bio-Tech And Lifescience has a workforce of 48 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aristo Bio-Tech And Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aristo Bio-Tech And Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.